Background: A wide variety of instruments have been used to assess the functional capabilities and health status of patients with chronic heart failure (I-F), but it is not known how well these tests are correlated with one another, nor which one has the best association with measured exercise capacity.
metabolic dysfunction, abnormal vasodilatory capacity, and abnormal distribution of blood flow.',' The degree of exercise intolerance is commonly used clinically to assess the severity of the disease and efficacy of therapy. Randomized clinical trials frequently use exercise duration or workload on a standardized exercise test as a primary outcome variable when assessing the efficacy of an intervention. The most accurate expression of exercise tolerance is directly measured peak oxygen uptake (peak VO~),''~ although numerous surrogates for peak VOz and other expressions of a patient's functional capabilities have been used, including symptom questionnaires, submaximal walking tests, and various functional classifi~ations.~-~ Peak VOz is rarely performed in clinical trials among patients with HF because of the added time, equipment, and technical expertise required to use ventilatory gas exchange equipment. Advantages of submaximal tests or health status and symptom questionnaires include that they are quick, inexpensive, and safe. Examples of health status and functional measures commonly used include the Kansas City Cardiomyopathy Questionnaire (KCCQ),' Veterans Specific Activity Questionnaire (VSAQ),~ Duke Activity Status Index (DASI):
6-minute walk distance, and New York Heart Association (NYHA) functional class.'0 Although it has been suggested that these measures can be unreliable because they may provide incomplete or misleading information,4.1 I-" some of these instruments have also been
shown to be sensitive to changes in clinical ~t a t u s . '~'~, '~ However, it is uncertain how well the commonly used measures of functional status in patients with I-IF are associated with clinical status measures, quality of life, or directly measured exercise capacity.
In the present study, we evaluated the association between peak VOz, clinical measures, and commonly used symptom and functional tools in patients with HE Our objectives were: (1) to evaluate the relationships between these functional assessments and to determine which is most strongly associated with peak VOp and (2) to determine the extent to which of these tools could be used to predict peak VOz.
Methods Patients
Forty-one male patients with stable HF (mean age 68 k 12 years) participated in the study. HF was documented by clinical history and diagnosis in outpatient medical records, and an ejection fraction (EF) <40%. Ischemic HF (n = 22) was defined by having a history of myocardial infarction, coronary bypass surgery, or documented angiographic coronary disease. Only patients with stable, compensated HF >30 years of age were included in the study. Written informed consent was obtained from all subjects using a protocol approved by the Stanford Investigational Review Board. Clinical characteristics of the study group are presented in Table 1 .
Exercise Testing
Symptom limited maximal exercise tests were performed on a treadmill using an individualized ramp protocol.'5 This test individualizes warm-up and peak walking speeds, along with the ramp rate (rate of change in speed and grade) to yield a test duration of approximately 10 All tests were performed in the morning. Before testing, standard pulmonary function tests were performed, including forced vital capacity (FVC) and forced expiratory volume in one second (FEV,). Ventilatoq oxygen uptake was measured using an Orca Diagnostics metabolic system (Santa B d a r a , CA). Gas exchange data were acquired breathby-breath and expressed in 10-s intervals of rolling 30-s averages. Ventilatory oxygen uptake, carbon dioxide production, minute ventilation, and respiratory exchange ratio were calculated online. The percentage of age-predicted normal peak V Q was determined for each patient using the equation of Wasserman et a1.I6 The ventilatory threshold was determined by 2 experienced, independent reviewers using the V-slope method," and confumed by ventilatory criteria. Estimated peak VOz was determined from the 
Symptom Questionnaires
Before undergoing exercise testing, responses to 4 symptom and health status questionnaires were obtained. These included the KCCQ,' VSAQ,~ DASI? and NYHA functional class.I0 The KCCQ is a detailed, disease-specific health status measure that encompasses domains including physical limitations, symptoms, disease severity, change in status over time, self-efficacy, social interference, and quality of life.' The DASI is a brief, self-adrninistered questionnaire designed to estimate functional status.' The VSAQ was similarly developed by our group and was specifically designed to estimate exercise tolerance before exercise testing to individualize the treadmill protocol for clinical exercise testing. The VSAQ score was age-adjusted6 The NYHA Functional Classification is a widely used general (4 categories), provider-derived classification scheme to categorize patients in terms of symptoms associated with daily activities.'' A description, metric, and ranges for each of the health status measurements is presented in Table 2 .
Six-Minute Walk Test
The 6-minute walk test was completed after the exercise test after a minimum 30-minute rest period, and performed as described by Guyattet a].' A 100-foot distance was marked in a hospital corridor, and patients were instructed to walk from end to end at their own pace, attempting to cover as great a distance as possible within 6 minutes. The test was supervised by a technician, who provided verbal encouragement at 30-second intervals. Patients were permitted to stop and rest, and were instructed to continue walking as soon as they felt they were able to do so. Symptoms experienced by the patient were recorded. Distance covered was expressed in meters.
Statistics
Simple univariate linear regression was performed to assess the relationships between peak V02 and the various functional and quality of life measures, including 6-minute walk distance, ageadjusted VSAQ score in metabolic equivalents (METS), functional capacity as determined by the DASI, the functional, clinical status, and quality of life domains of the KCCQ (each expressed in 0 to 100 scales), NYHA functional class, V02 at the ventilatory threshold, and peak METS estimated from treadmill speed and grade. Using the pretest variables with the strongest univariate associations with peak V02 (age, 6-minute walk distance, VSAQ score, FVC, and KCCQ quality of life swre), a forward stepwise multiple regression procedure was performed to predict peak VOz. A second multiple regression procedure was performed to determine predictors of estimated METS achieved (from peak treadmill speed and grade), using the variables with the strongest univariate associations with estimated METS (age, DASI, VSAQ, 6-minute walk distance, and KCCQ physical limitation score).
Results

Exercise Test Responses
Exercise test results are listed in Table 3 . The mean maximal perceived exertion was 17.6 f 2.0, and the mean peak respiratory exchange ratio was 1.14 + 0.23, suggesting that maximal effort was achieved by most patients. The mean maximal heart rate of 124 + 28 beatdmin was lower than that expected for age (82% of predicted), reflecting that many patients were limited by symptoms associated with HF, that heart rate was limited by the effects of f3-blockade, or both. Mean maximal oxygen uptake was 16.1 + 6.2 mL.kg.min (representing 54 f 22% of age-predicted peak V a ) , and the ventilatory threshold occurred at 76% of peak V02. Table 4 . The mean NYHA functional class was 1.7 2 0.98. METS from the VSAQ (6.6 f 2.0) were higher than that achieved on the treadmill expressed as measured peak V02 (4.5 + 1.8, P < .01), and METS estimated from peak treadmill speed and grade (5.4 2 2.2, P < .05). Mean 6-minute walk distance was 328 f 97 meters.
Association Between Functional Measures and Peak V02
Correlation coefficients between peak V02 and the various functional measures are presented in Table 5 . Both estimated METS and V02 at the ventilatory threshold were significantly associated with peak V02 (r = 0.72 and 0.76, P < .001 and P < .W1, respectively). Among the non-exercise test health status measures, peak V02 had significant associations with the VSAQ score (r = 0.37, P < .05), but not with the DASI (r = 0.26) or NYHA class (r = -0.14). Among the KCCQ domains, peak V02 was significantly associated with quality of life score (r = 0.46, P < .05), but not with physical limitation, symptom, or clinical summary scores. Six-minute walk distance was significantly though modestly related to peak V02 (r = 0.49, P < .01), KCCQ physical limitation (r = 0.53, P < .01), and clinical summary scores (r = 0.44, P < .05).
Among pretest clinical indices (age, heart rate, EF, FVC, FEVI), only age and EF were related to peak VOz (-0.58, P < .001 and 0.46, P < .01, respectively).
The associations between the various functional and health status measures and peak V02 were similar when those with nonischemic HF were assessed separately.
Multivariate Predictors of Peak VOa
Predictors of peak V02 by multiple regression are presented in Table 6 . Age explained the greatest proportion of variance in peak V02 (49%) followed by the KCCQ quality of life score (23%). Six-minute walk performance was not a significant multivariate determinant of peak V02. The final regression equation for peak V02 was To compare the current sample of HF patients with our previous results among exercise test referrals (largely non-HF) in which peak estimated METS was the dependent ~ariable?.'~ a second analysis was performed. Only VSAQ score (3 = 0.34), age (additional ? = 0.15%), and KCCQ physical limitation score (additional ? = 16%) were significant predictors of peak estimated METS (multiple r for model = 0.81, P < .001) ( Table 7) .
Discussion
The present results suggest that commonly-used functional measures, estimates of quality of life, and symptom tools in patients with HF generally have only modest associations with peak VOz and with one another. The clinical implications of these findings are that: (1) each test or instrument targets a specific aspect of clinical status and they should not be considered interchangeable and (2) none of these measures alone is a reliable surrogate for peak V02.
Peak V02 was used as the dependent variable because it is widely recognized as the standard measure of cardiopulmonary function and has wide applications for risk stratification in m3, 16,20.2 I It should be noted, however, that not all the independent variables employed in the present study were designed specifically to estimate maximal cardiopulmonary function, even though many of them have been used to quantify functional changes in clinical trials. The lack of strong associations between the various functional measures is likely explained in part by the fact that they assess different aspects of functional status. These observations also highlight the complexity of HF, many factors interact to underlie exercise intolerance in a given patient,'.2.'6'm symptoms can vary from day to day, and progression of the disease can be unpredictable, leading to a divergence in physiologic function, clinical status, and quality of life. None of the symptom tools had a strong association with peak V a ; correlation coefficients between peak V& and these instruments were in the order of 0.20 to 0.40 ( Table 5) .
The relationship between peak V& and the VSAQ (r = 0.37) is similar to what we previously observed using this measure in a more hetemgeneous sample of patients re- Although quality of life would be expected to be closely related to one's exercise capabilities, studies associating quality of life and exercise tolerance have been mixed. Arena et al" observed that the Minnesota Living with Heart Failure Questionnaire (MLHF) was significantly related to peak V02 in patients with HF (r = 0.66, P < .001), though it was poorly related to the VENC02 slope. Koukouvou and colleagues28 reported that the MLHF and other quality of life scores closely paralleled improvements in peak V02 and other cardiopulmonary exercise test responses before and after 6 months in a rehabilitation program. Conversely, Wilson and colleagues29 reported poor relationships between perceived exercise tolerance as measured by the MLHF and objective measures of circulatory or ventilatory performance. Grigioni et a130 observed poor relationships between the majority of objective clinical markers of disease severity (peak V02, presence of a third heart sound, signs of fluid retention, electrocardiogram findings, EF, and echocardiographic variables) and the MLHF. Juenger et a13' reported that the physical function domain of the Medical Outcomes Study (SF-36) was significantly related to peak V02 (r = 0.47, P < .001), but the other 7 SF-36 domains were generally poorly associated with peak V02 (r = 0.16 to 0.40). In accordance with these studies, peak V02 had relatively poor relationships with subjective symptom measures in the present study (r = -0.14 to 0.30), although a significant association was observed between peak VOz and KCCQ quality of life score (r = 0.46, P < .05).
Association of &Minute Walk Performance With Functional Measures
The 6-minute walk test has been widely used in the evaluation and serial assessment of ~atients with HF.' . ' 3.32-35 Our HF patients were similar to those in previous studies in that their mean 6-minute walk distance was 328 + 93 meter^.^*-^' Previous studies have reported correlation coefficients between 6-minute walk performance and peak V02 among patients with HF in the range of 0.50 to 0.70.32,34,36-40 The association we observed between 6-minute walk distance and peak V02 (r = 0.49) was comparable to these previous studies. It might be expected that 6-minute walk performance, as a submaximi measure, would be more closely associated with questionnaires designed to reflect symptom limitations during daily activities than peak V02. However, although we observed that 6-minute walk distance had a modest association with KCCQ physical limitation score (r = 0.53, P < .01), it was poorly related to KCCQ symptom and quality of life scores. In developing the KCCQ, Green et a18 originally observed a correlation of 0.48 between the physical limitation score and 6-minute walk distance, which is similar to other studies associating various quality of life instruments to 6-minute walk performance.30s31 These studies suggest that although 6-minute walk performance may not be &ap-propriate surrogate for peak VOz, it is a modest reflection of functional status assessed by questionnaire.
Functional Status Measures and EF
Another potentially useful clinical application relates to whether simple, noninvasive functional measures and exercise test responses are associated with a clinical index such as EF. In previous studies, both 6-minute walk performance and exercise test responses have been shown to relate poorly to EF and other hemodynamic variables in rn34,38.39 Although we observed that EF had a stronger relation with peak V02 than most previous studies, the relationship was modest (r = 0.46, P < .01). Among the other functional measures, the highest correlation with EF was for dminute walk performance, but the relationship was relatively weak (r = 0.28). EF also did not have strong associations with the KCCQ domains, ranging from 0.24 for the physical limitation to 0.54 for the quality of life score. The absence of strong relationships between EF and HF-specific quality of life measures has been observed by other i n~e s t i~a t o r s .~'~~'~~~
Multivariate Analysis
We observed that the multivariate model explained 72% of the variance in peak V a , with age accounting for the greatest amount of variance (49%). That age accounted for the greatest amount of variance in peak VOz is not surprising, given the decline in peak V02 that occurs with aging regardless of disease presence, and the greater likelihood of comorbidities and more severe disease in older subjects. Interestingly, the KCCQ quality of life score was the only health status measure that contributed significantly to the model, adding 23% to the variance explained. Similar to our previous study among consecutive exercise test referrals (largely without HF) in which the combination VSAQ score and age were the only significant predictors of estimated exercise capacity (multiple r = 0.79); age and VSAQ score were significant predictors of estimated METS achieved in the present study, along with the KCCQ physical limitation score (multiple r = 0.81). These results suggest that when exercise testing is unavailable, exercise capacity might be reasonably estimated multivariately by considering age and a non-exercise test assessment tool.
Limitations
The study sample size was relatively small. We did not employ practice trials for maximal exercise testing or the 6-minute walk test, both of which are known to improve with repetition.7.3294"he study was limited to men, and the sample was a heterogeneous group of patients with HF, our findings may not apply to women or specific subgroups of HE In addition, the sample was a comparatively healthy group of patients with HF, and the results may have differed in patients with more severe HE
Summary
Health status, including functional capabilities, symptoms associated with daily activities, and physical or psychologic well-being are important indices that are widely used in the assessment of interventions for HF. Accurate and reliable tools that quantify health status are important to appropriately assess responsiveness to therapy in this population. We observed that tools commonly used to assess health and functional status in HF had only modest associations with peak VO2 and with one-another. In practical terms, this suggests that: (1) laboratory exercise tolerance is not necessarily a good reflection of how patients perceive their capacity to undertake daily activities and (2) cardiopulmonary exercise testing, non-exercise test estimates of physical function, and quality of life measures reflect different facets of health status and one should not be considered a surrogate for another. These findings may have applications for the design and interpretation of clinical trials in which estimates of exercise tolerance are used as efficacy parameters in patients with HE
